Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 747 clinical trials
None
  • 0 views
  • 22 Jan, 2021
  • 7 locations
None
A Study to Assess LBL-007 in Combination With Toripalimab Subjects With Advanced Melanoma

A phase I clinical study evaluating LBL-007 in the treatment of subjects with advanced solid tumors

  • 1 views
  • 19 Jan, 2022
  • 7 locations
None
Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

Single arm study with dose escalation Phase Ib cohort followed by a Phase II cohort. PAC-1 (PO) will be given daily on Days 1 through 21 of each cycle (28-day cycle). Entrectinib (PO) will be given daily on Days 1 through 28 of each cycle. Response will be evaluated after …

  • 0 views
  • 19 Jan, 2022
  • 1 location
None
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation

An open-label, multicenter phase II clinical study to evaluate safety, efficacy and PK of HLX208 for advanced melanoma with BRAF V600 mutation

  • 0 views
  • 19 Jan, 2022
  • 1 location
None
Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis

This phase II study will evaluate the safety of combining intermediate frequency electric field (TT Field) with immunotherapy in melanoma patients with brain metastasis. The data of this study

  • 0 views
  • 22 Aug, 2021
  • 1 location
None
Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma

This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.

  • 0 views
  • 01 May, 2021
  • 1 location
None
MEK and Autophagy Inhibition in Metastatic/Locally Advanced Unresectable Neuroblastoma RAS (NRAS) Melanoma

Patients with metastatic Neuroblastoma RAS (NRAS) melanoma are currently treated with first line immune checkpoint inhibitors (nivolumab, pembrolizumab). Thus far, no targeted therapy has been

  • 0 views
  • 25 Jan, 2021
  • 5 locations
None
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes

unresectable or metastatic melanoma. The study team wants to know the effectiveness of these drugs together in treating cancer than if each study drug was given by itself.

  • 0 views
  • 15 May, 2021
  • 2 locations
None
Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma

Approximately 40 participants with locally advanced or metastatic melanoma will be enrolled in 20 sites in the United States into 1 of the following 2 arms: Primary resistance to initial

  • 0 views
  • 03 Jan, 2022
  • 11 locations
None
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

pembrolizumab on local tumor control in mucosal melanoma patients. Treatment effect will be compared with historical radiation therapy-alone control data.

  • 0 views
  • 19 Jan, 2022
  • 1 location